Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nature Communications|February 22, 2024
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelinesAlexander P L Martindale, Carrie D Llewellyn, Richard O de Visser, et al.
Cancer Cell|February 13, 2020
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial CellsZhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi, et al.
BMC Pregnancy and Childbirth|February 12, 2022
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional studySiang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
BMC Medicine|January 16, 2023
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, et al.
BMJ Open|February 24, 2023
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UKSiang Ing Lee, Holly Hope, Dermot O'Reilly, et al.
BMJ Open|October 9, 2023
Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocolAnuradhaa Subramanian, Siang Ing Lee, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, et al.
Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
JCI Insight|May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Pageof 10